1-8 of 8
Anindita Chakrabarty
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trastuzumab-Resistant Cells Rely on a HER2-PI3K-FoxO-Survivin Axis and Are Sensitive to PI3K Inhibitors

Anindita Chakrabarty, Neil E. Bhola, Cammie Sutton, Ritwik Ghosh, María Gabriela Kuba, Bhuvanesh Dave, Jenny C. Chang, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2013) 73 (3): 1190–1200.
https://doi.org/10.1158/0008-5472.CAN-12-2440
Published: 31 January 2013
View article titled, Trastuzumab-Resistant Cells Rely on a HER2-PI3K-FoxO-Survivin Axis and Are Sensitive to PI3K Inhibitors
Open the PDF for Trastuzumab-Resistant Cells Rely on a HER2-PI3K-FoxO-Survivin Axis and Are Sensitive to PI3K Inhibitors in another window
Includes: Supplementary data
Journal Articles

Abstract 3: HER2 gene-amplified human breast cancer cells harboring a gatekeeper T768M mutation in HER2 overexpress EGFR ligands and are sensitive to dual therapeutic blockade of EGFR and HER2

Ritwik Ghosh, Archana Narasanna, Anindita Chakrabarty, Jeffrey A. Engelman, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3.
https://doi.org/10.1158/1538-7445.AM2012-3
Published: 15 April 2012
View article titled, Abstract 3: HER2 gene-amplified human breast cancer cells harboring a gatekeeper T768M mutation in HER2 overexpress EGFR ligands and are sensitive to dual therapeutic blockade of EGFR and HER2
Journal Articles

ErbB3 Ablation Impairs PI3K/Akt-Dependent Mammary Tumorigenesis

Rebecca S. Cook, Joan T. Garrett, Violeta Sánchez, Jamie C. Stanford, Christian Young, Anindita Chakrabarty, Cammie Rinehart, Yixian Zhang, Yaming Wu, Lee Greenberger, Ivan D. Horak, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2011) 71 (11): 3941–3951.
https://doi.org/10.1158/0008-5472.CAN-10-3775
Published: 31 May 2011
View article titled, ErbB3 Ablation Impairs PI3K/Akt-Dependent Mammary Tumorigenesis
Open the PDF for ErbB3 Ablation Impairs PI3K/Akt-Dependent Mammary Tumorigenesis in another window
Includes: Supplementary data
Journal Articles

Abstract 231: Upregulation of HER3 (ErbB3) levels and function counteracts the antitumor effect of HER2 and PI3K inhibitors

Joan Garrett, Cammie Rinehart, Anindita Chakrabarty, Bhuvanesh Dave, William Pao, Charles Manning, Jenny Chang, Carlos Arteaga
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 231.
https://doi.org/10.1158/1538-7445.AM2011-231
Published: 15 April 2011
View article titled, Abstract 231: Upregulation of HER3 (ErbB3) levels and function counteracts the antitumor effect of HER2 and PI3K inhibitors
Journal Articles

Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

Ritwik Ghosh, Archana Narasanna, Shizhen Emily Wang, Shuying Liu, Anindita Chakrabarty, Justin M. Balko, Ana María González-Angulo, Gordon B. Mills, Elicia Penuel, John Winslow, Jeff Sperinde, Rajiv Dua, Sailaja Pidaparthi, Ali Mukherjee, Kim Leitzel, Wolfgang J. Kostler, Allan Lipton, Michael Bates, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2011) 71 (5): 1871–1882.
https://doi.org/10.1158/0008-5472.CAN-10-1872
Published: 01 March 2011
View article titled, Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers
Open the PDF for Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers in another window
Includes: Supplementary data
Journal Articles

Abstract #440: H1047R PIK3CA mutant enhances HER2-mediated transformation via heregulin production and activation of HER3 in human mammary epithelial cells

Anindita Chakrabarty, Brent Rexer, Jeffrey Engelman, Carlos Arteaga
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 440.
Published: 01 May 2009
View article titled, Abstract #440: H1047R <em>PIK3CA</em> mutant enhances HER2-mediated transformation via heregulin production and activation of HER3 in human mammary epithelial cells
Journal Articles

Stable expression of exon 9 and exon 20 mutant PIK3CA enhances HER2-mediated transformation in MCF-10A human mammary epithelial cells

Anindita Chakrabarty, Brent Rexer, Carlos Arteaga
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 124.
Published: 01 May 2008
View article titled, Stable expression of exon 9 and exon 20 mutant <em>PIK3CA</em> enhances HER2-mediated transformation in MCF-10A human mammary epithelial cells
Journal Articles

Extracellular Signal-Regulated Kinase Is a Target of Cyclooxygenase-1-Peroxisome Proliferator-Activated Receptor-δ Signaling in Epithelial Ovarian Cancer

Takiko Daikoku, Susanne Tranguch, Anindita Chakrabarty, Dingzhi Wang, Dineo Khabele, Sandra Orsulic, Jason D. Morrow, Raymond N. DuBois, Sudhansu K. Dey
Journal: Cancer Research
Cancer Res (2007) 67 (11): 5285–5292.
https://doi.org/10.1158/0008-5472.CAN-07-0828
Published: 01 June 2007
View article titled, Extracellular Signal-Regulated Kinase Is a Target of Cyclooxygenase-1-Peroxisome Proliferator-Activated Receptor-δ Signaling in Epithelial Ovarian Cancer
Open the PDF for Extracellular Signal-Regulated Kinase Is a Target of Cyclooxygenase-1-Peroxisome Proliferator-Activated Receptor-δ Signaling in Epithelial Ovarian Cancer in another window
Includes: Supplementary data